Trilogy Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.53M Buy
41,705
+2,148
+5% +$173K 0.14% 126
2026
Q1
$2.8M Buy
39,557
+1,123
+3% +$84.1K 0.12% 131
2025
Q4
$3.03M Buy
+38,434
New +$3.04M 0.14% 127
2018
Q4
Sell
-31
Closed -$1K 397
2018
Q3
$1K Hold
31
﹤0.01% 570
2018
Q2
$1K Sell
31
-3
-9% -$140 ﹤0.01% 529
2018
Q1
$2K Buy
+34
New +$1.65K ﹤0.01% 393

Other funds holding MET

Trilogy Capital's MET Position: Q2 2026 in Review

Trilogy Capital increased its MetLife (MET) stake by 5.4% in Q2 2026, buying an estimated $173K and bringing the position to 41,705 shares worth $3.53M. The position accounts for 0.14% of the portfolio, ranked #126.

Trilogy Capital first reported a position in MET in Q1 2018 and has held it in 6 quarters since. 219 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Trilogy Capital held 41,705 shares of MetLife worth $3.53M as of Q2 2026.
  • Trilogy Capital bought 2,148 MetLife shares in Q2 2026, an estimated $173K.
  • MetLife made up 0.14% of Trilogy Capital's portfolio in Q2 2026, its #126 holding.
  • Trilogy Capital first reported a position in MetLife in Q1 2018 and has held it in 6 quarters since.
  • 219 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.